J&J says second shot boosts protection for moderate-severe Covid-19 to 94 percent

Johnson & Johnson has said a second shot of its Covid-19 vaccine increased its effectiveness to 94 percent against moderate to severe forms of the disease.

Powered by NewsAPI , in News on .

news image
Johnson & Johnson has said a second shot of its Covid-19 vaccine increased its effectiveness to 94 percent against moderate to severe forms of the disease.
Read More